Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Immunity|September 21, 2018
Tissue Crosstalk in T1D: Is Insulin Special?Braxton L Jamison, Kathryn HaskinsCurrent Opinion in Endocrinology, Diabetes, and Obesity|June 6, 2019
Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetesRocky L Baker, Braxton L Jamison, Kathryn HaskinsJournal of Immunology (Baltimore, Md. : 1950)|May 22, 2019
Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T CellsBraxton L Jamison, Tobias Neef, Andrew Goodspeed, et al.Diabetes|July 7, 2018
CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD MouseRocky L Baker, Braxton L Jamison, Timothy A Wiles, et al.Diabetes|January 10, 2022
Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the NOD MouseBraxton L Jamison, James E DiLisio, K Scott Beard, et al.Advances in Immunology|August 17, 2005
Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouseKathryn HaskinsCurrent Opinion in Immunology|September 16, 2011
CD4 T cells and their antigens in the pathogenesis of autoimmune diabetesKathryn Haskins, Anne CookeJournal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alphaJoseph Cantor, Kathryn HaskinsJournal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1Joseph Cantor, Kathryn HaskinsCritical Reviews in Immunology|January 19, 2021
Cluster of Differentiation 4 T Cells and Neoantigens in Autoimmune DiabetesKathryn Haskins, Janet WenzlauPageof 8